A
Price
$112.04
Change
-$1.95 (-1.71%)
Updated
Jul 21 closing price
Capitalization
42.66B
36 days until earnings call
APYX
Price
$2.24
Change
-$0.02 (-0.88%)
Updated
Jul 21 closing price
Capitalization
47.46M
16 days until earnings call
Interact to see
Advertisement

A vs APYX

Header iconA vs APYX Comparison
Open Charts A vs APYXBanner chart's image
Agilent Technologies
Price$112.04
Change-$1.95 (-1.71%)
Volume$2.06M
Capitalization42.66B
Apyx Medical
Price$2.24
Change-$0.02 (-0.88%)
Volume$39.47K
Capitalization47.46M
A vs APYX Comparison Chart in %
Loading...
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
APYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
A vs. APYX commentary
Jul 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is A is a StrongBuy and APYX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 22, 2025
Stock price -- (A: $112.04 vs. APYX: $2.24)
Brand notoriety: A and APYX are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: A: 99% vs. APYX: 47%
Market capitalization -- A: $42.66B vs. APYX: $47.46M
A [@Medical Specialties] is valued at $42.66B. APYX’s [@Medical Specialties] market capitalization is $47.46M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

A’s FA Score shows that 1 FA rating(s) are green whileAPYX’s FA Score has 0 green FA rating(s).

  • A’s FA Score: 1 green, 4 red.
  • APYX’s FA Score: 0 green, 5 red.
According to our system of comparison, A is a better buy in the long-term than APYX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

A’s TA Score shows that 4 TA indicator(s) are bullish while APYX’s TA Score has 3 bullish TA indicator(s).

  • A’s TA Score: 4 bullish, 5 bearish.
  • APYX’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, A is a better buy in the short-term than APYX.

Price Growth

A (@Medical Specialties) experienced а -6.70% price change this week, while APYX (@Medical Specialties) price change was +13.71% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +2.48%. For the same industry, the average monthly price growth was +3.97%, and the average quarterly price growth was -1.94%.

Reported Earning Dates

A is expected to report earnings on Aug 27, 2025.

APYX is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Medical Specialties (+2.48% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
A($42.7B) has a higher market cap than APYX($47.5M). APYX YTD gains are higher at: 41.772 vs. A (-16.246). A has higher annual earnings (EBITDA): 1.69B vs. APYX (-18.11M). APYX has less debt than A: APYX (38.5M) vs A (2.56B). A has higher revenues than APYX: A (6.74B) vs APYX (52.3M).
AAPYXA / APYX
Capitalization42.7B47.5M89,895%
EBITDA1.69B-18.11M-9,331%
Gain YTD-16.24641.772-39%
P/E Ratio34.82N/A-
Revenue6.74B52.3M12,878%
Total CashN/A43.7M-
Total Debt2.56B38.5M6,636%
FUNDAMENTALS RATINGS
A vs APYX: Fundamental Ratings
A
APYX
OUTLOOK RATING
1..100
7468
VALUATION
overvalued / fair valued / undervalued
1..100
20
Undervalued
57
Fair valued
PROFIT vs RISK RATING
1..100
72100
SMR RATING
1..100
4899
PRICE GROWTH RATING
1..100
5691
P/E GROWTH RATING
1..100
67100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

A's Valuation (20) in the Biotechnology industry is somewhat better than the same rating for APYX (57) in the Medical Specialties industry. This means that A’s stock grew somewhat faster than APYX’s over the last 12 months.

A's Profit vs Risk Rating (72) in the Biotechnology industry is in the same range as APYX (100) in the Medical Specialties industry. This means that A’s stock grew similarly to APYX’s over the last 12 months.

A's SMR Rating (48) in the Biotechnology industry is somewhat better than the same rating for APYX (99) in the Medical Specialties industry. This means that A’s stock grew somewhat faster than APYX’s over the last 12 months.

A's Price Growth Rating (56) in the Biotechnology industry is somewhat better than the same rating for APYX (91) in the Medical Specialties industry. This means that A’s stock grew somewhat faster than APYX’s over the last 12 months.

A's P/E Growth Rating (67) in the Biotechnology industry is somewhat better than the same rating for APYX (100) in the Medical Specialties industry. This means that A’s stock grew somewhat faster than APYX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AAPYX
RSI
ODDS (%)
Bearish Trend 1 day ago
60%
Bearish Trend 1 day ago
76%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
60%
Bullish Trend 1 day ago
88%
Momentum
ODDS (%)
Bearish Trend 1 day ago
52%
Bearish Trend 1 day ago
86%
MACD
ODDS (%)
Bearish Trend 1 day ago
48%
Bearish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
61%
Bullish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
63%
Bullish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 6 days ago
61%
Bullish Trend 6 days ago
86%
Declines
ODDS (%)
Bearish Trend 1 day ago
60%
Bearish Trend 1 day ago
85%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
61%
Bearish Trend 1 day ago
87%
Aroon
ODDS (%)
Bullish Trend 1 day ago
62%
Bullish Trend 1 day ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
APYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ZUMZ13.900.44
+3.27%
Zumiez
NWN42.210.68
+1.64%
Northwest Natural Holding Company
LIN470.435.42
+1.17%
Linde plc
WTFC131.38-2.69
-2.01%
Wintrust Financial Corp
INTG10.76-0.48
-4.27%
Intergroup Corp

A and

Correlation & Price change

A.I.dvisor indicates that over the last year, A has been closely correlated with MTD. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if A jumps, then MTD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To A
1D Price
Change %
A100%
-1.71%
MTD - A
85%
Closely correlated
-2.37%
RVTY - A
80%
Closely correlated
-2.72%
TMO - A
79%
Closely correlated
-2.37%
WAT - A
79%
Closely correlated
-1.97%
BRKR - A
76%
Closely correlated
-12.12%
More

APYX and

Correlation & Price change

A.I.dvisor tells us that APYX and SMTI have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that APYX and SMTI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APYX
1D Price
Change %
APYX100%
-0.88%
SMTI - APYX
25%
Poorly correlated
-0.11%
RDNT - APYX
25%
Poorly correlated
+0.78%
ESTA - APYX
25%
Poorly correlated
+2.48%
FSPKF - APYX
25%
Poorly correlated
N/A
ICLR - APYX
25%
Poorly correlated
-2.72%
More